Skip to main content

Volume 2 Supplement 1

12th International Transplantation Symposium


Edited by Edward K Geissler and Alan Jardine

The symposium and publication were supported by an unrestricted educational grant from Pfizer Inc, who had no influence on the editorial content. Editorial support was provided by Synergy, Richmond, UK and was funded by Pfizer Inc. Rapamune (sirolimus) is a product marketed by Pfizer Inc. The articles have been through the journal's standard peer review process and the Supplement Editors declare that they have no competing interests.

12th International Transplantation Symposium.

Istanbul, Turkey16-17 April 2012

  1. JAK3 inhibition with the CP-690,550 compound has an immunosuppressive potency in murine models, nonhuman primates and humans. This drug blocks STAT5 activation in most T-cell subpopulations but less effectivel...

    Authors: Christophe Legendre
    Citation: Transplantation Research 2013 2(Suppl 1):S6